Dazodalibep Clinical Trials (2026): 3 Studies for Sjogren's Syndrome & Sjögren's Syndrome
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
3 Dazodalibep clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 3 indications (including Sjogren's Syndrome & Sjögren's Syndrome) and 1,929 total planned enrollment. 3 Phase 3 Dazodalibep trials are listed. 1 Dazodalibep clinical trial is actively recruiting at 31 U.S. sites across 14 states. Most recent activity: NCT06747949 (Dec 2029).
Where to Participate: All Dazodalibep Trial Sites in the U.S. (31 sites across 14 states)
Every actively recruiting Dazodalibeptrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| AZ | Arizona Arthritis & Rheumatology Associates - Avondale | Avondale85392 | NCT06747949 | Map |
| AZ | Arizona Arthritis and Rheumatology Associates - Flagstaff - 399 S Malpais Ln | Flagstaff86001-6269 | NCT06747949 | Map |
| AZ | Arizona Arthritis and Rheumatology Associates - Gilbert - 3645 S Rome St | Gilbert85297-7336 | NCT06747949 | Map |
| AZ | Arizona Arthritis and Rheumatology Associates - Glendale - 5681 W Beverly Ln | Glendale85306-9800 | NCT06747949 | Map |
| AZ | Arizona Arthritis and Rheumatology Associates - Tucson - 2001 W Orange Grove Rd | Tucson85704-1139 | NCT06747949 | Map |
| CA | Samy Metyas MD Inc | Covina91723 | NCT06747949 | Map |
| CA | UCSD Altman Clinical and Translational Research Institute Building | La Jolla92037-1337 | NCT06747949 | Map |
| CO | Tekton Research, LLC - 2121 E Harmony Rd - PPDS | Fort Collins80528-3400 | NCT06747949 | Map |
| FL | Bradenton Research Center Inc | Bradenton34205-1704 | NCT06747949 | Map |
| FL | Clinical Research of West Florida Inc - Clearwater | Clearwater33765-2616 | NCT06747949 | Map |
| FL | BayCare Medical Group Primary Care and Rheumatology - Tampa | Tampa33614-7101 | NCT06747949 | Map |
| MA | Tufts University School of Dental Medicine | Boston02111-1527 | NCT06747949 | Map |
| MI | Shores Rheumatology | Saint Clair Shores48081-1274 | NCT06747949 | Map |
| MO | Kansas City Physician Partners-8350 N Saint Clair Ave | Kansas City64151 | NCT06747949 | Map |
| NJ | Arthritis, Rheumatic & Bone Disease Associates - Voorhees | Voorhees Township08043-4501 | NCT06747949 | Map |
| NC | Arthritis and Osteoporosis Consultants of The Carolinas - Charlotte - 1918 Randolph Rd | Charlotte28207-1100 | NCT06747949 | Map |
| NC | Duke Early Phase Clinical Research Unit - PPDS | Durham27710-0001 | NCT06747949 | Map |
| NC | Onsite Clinical Solutions, LLC - Salisbury | Salisbury28144 | NCT06747949 | Map |
| OH | Arthritis & Osteoporosis Center of Southwest Ohio - Miamisburg | Miamisburg45342-3585 | NCT06747949 | Map |
| OH | University of Toledo Medical Center | Toledo43614-2595 | NCT06747949 | Map |
| OH | STAT Research-600 Aviator Ct | Vandalia45377-9474 | NCT06747949 | Map |
| TN | Murfreesboro Medical Clinic Westlawn | Murfreesboro37128 | NCT06747949 | Map |
| TX | Accurate Clinical Management-Baytown | Baytown77521-2279 | NCT06747949 | Map |
| TX | Precision Comprehensive Clinical Research Solutions | Colleyville76034-5913 | NCT06747949 | Map |
| TX | Houston Rheumatology & Arthritis Specialists - PLLC - PPDS | Katy77494-1341 | NCT06747949 | Map |
| TX | R & H Clinical Research-777 S Fry Rd | Katy77450-2297 | NCT06747949 | Map |
| TX | Biopharma Informatic - Ridge Road - PPDS | McAllen78503-1527 | NCT06747949 | Map |
| TX | Advanced Rheumatology of Houston | The Woodlands77382-2935 | NCT06747949 | Map |
| TX | DM Clinical Research - Migraine and COPD - PPDS | Tomball77375 | NCT06747949 | Map |
| WA | Western Washington Medical Group, Bothell - Rheumatology | Bothell98021 | NCT06747949 | Map |
| WV | Rheumatology and Pulmonary Clinic | Beckley25801-2805 | NCT06747949 | Map |
Dazodalibep clinical trials at a glance: phase × recruitment status
| Phase | recruiting | active not recruiting | Total |
|---|---|---|---|
| P3 | 1 | 2 | 3 |
Recruiting Dazodalibep clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT06747949 | SSA Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) | P3 | Sjögren's Syndrome | 844 | Feb 2025 |
Dazodalibep clinical trials by indication
Sjögren's Syndrome (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06747949 | SS | P3 | recruiting | A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) |
Sjögren's Syndrome (SS) (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06245408 | SS | P3 | active not recruiting | A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State |
Sjogren's Syndrome (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06104124 | SS | P3 | active not recruiting | A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity |
Dazodalibep pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| SS | NCT06747949 | P3 | recruiting | Sjögren's Syndrome | 844 | — |
| SS | NCT06245408 | P3 | active not recruiting | Sjögren's Syndrome (SS) | 434 | — |
| SS | NCT06104124 | P3 | active not recruiting | Sjogren's Syndrome | 651 | — |
All Dazodalibep trials (3)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT06747949 | SS | A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) | P3 | recruiting | 844 | Amgen | Feb 2025 |
| NCT06245408 | SS | A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State | P3 | active not recruiting | 434 | Amgen | Apr 2024 |
| NCT06104124 | SS | A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity | P3 | active not recruiting | 651 | Amgen | Jan 2024 |
Dazodalibep clinical trials: frequently asked questions
- How many Dazodalibep clinical trials are there?
- 3 Dazodalibep clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are Dazodalibep clinical trials recruiting in 2026?
- Yes — 1 Dazodalibep trial is actively recruiting in 2026, with 31 U.S. sites across 14 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is Dazodalibep being studied for?
- Dazodalibep is being studied for Sjogren's Syndrome, Sjögren's Syndrome, Sjögren's Syndrome (SS). The trials are grouped by indication on this page.
- What phase is Dazodalibep in?
- Dazodalibep clinical trials span 3 Phase 3. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors Dazodalibep clinical trials?
- The lead sponsor across the most Dazodalibep trials is Amgen. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Dazodalibepas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: